Home

DENNIS MULROY

CIK 1276840 · Chief Financial Officer · last filed 2026-05-07

DENNIS MULROY is a Chief Financial Officer who has filed 96 SEC Form 4 insider transactions across 4 companies since 2009. The most recent filing, for ANAB, was dated Jun 29, 2026. Across all open-market trades the lifetime net is −$2.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.3M across reported positions. 52 SEC filings were submitted jointly with ANAPTYSBIO, INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.31M

Companies

4

Total Filings

96

Lifetime Open-Market Net

-$2.29M

Filer Profile

Reported Address
10421 PACIFIC CENTER COURT
SUITE 200
SAN DIEGO, CA 92121
Related Filers
ANAPTYSBIO, INC — 52 joint filings, latest 2026-06-29
PHARMACEUTICAL CO LA JOLLA — 43 joint filings, latest 2020-06-02
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ARCT Chief Financial Officer — $14.73 — $0 1 2026-05-07
ANAB CHIEF FINANCIAL OFFICER 24,367 $53.87 $1.31M -$2.31M 20 2026-01-09
LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted Chief Financial Officer 5,067 $6.22 $31.5K $17.0K 42 2020-06-02
CXM Chief Financial Officer — $5.48 — $0 1 2009-03-17

Recent Filings

96 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-29 ANAB Notice (144) −9,476 -$601.2K EDGAR
2026-06-26 ANAB Notice (144) −10,000 -$608.2K EDGAR
2026-06-17 ANAB Notice (144) −850 -$51.0K EDGAR
2026-06-16 ANAB Notice (144) −1,265 -$75.9K EDGAR
2026-06-15 ANAB Notice (144) −20,000 -$1.15M EDGAR
2026-06-12 ANAB Notice (144) −20,000 -$1.11M EDGAR
2026-06-11 ANAB Notice (144) −35,000 -$1.85M EDGAR
2026-06-10 ANAB Notice (144) −20,000 -$1.05M EDGAR
2026-06-09 ANAB Notice (144) −20,000 -$1.03M EDGAR
2026-06-08 ANAB Notice (144) −21,987 -$1.12M EDGAR
Showing 1–10 of 96
Page 1 of 10
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.